HomeCompareTGRNF vs NNN

TGRNF vs NNN: Dividend Comparison 2026

TGRNF yields 4.55% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TGRNF wins by $7.0K in total portfolio value
10 years
TGRNF
TGRNF
● Live price
4.55%
Share price
$0.55
Annual div
$0.03
5Y div CAGR
9.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.5K
Annual income
$1,748.22
Full TGRNF calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — TGRNF vs NNN

📍 TGRNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTGRNFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TGRNF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TGRNF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TGRNF
Annual income on $10K today (after 15% tax)
$386.94/yr
After 10yr DRIP, annual income (after tax)
$1,485.99/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, NNN beats the other by $743.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TGRNF + NNN for your $10,000?

TGRNF: 50%NNN: 50%
100% NNN50/50100% TGRNF
Portfolio after 10yr
$29.0K
Annual income
$2,185.45/yr
Blended yield
7.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

TGRNF
No analyst data
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TGRNF buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTGRNFNNN
Forward yield4.55%5.66%
Annual dividend / share$0.03$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.4%8.6%
Portfolio after 10y$32.5K$25.5K
Annual income after 10y$1,748.22$2,622.67
Total dividends collected$10.0K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: TGRNF vs NNN ($10,000, DRIP)

YearTGRNF PortfolioTGRNF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$11,198$498.01$10,735$614.96+$463.00TGRNF
2$12,552$570.18$11,572$708.43+$980.00TGRNF
3$14,084$653.46$12,531$819.53+$1.6KTGRNF
4$15,820$749.67$13,633$952.29+$2.2KTGRNF
5$17,788$860.93$14,909$1,111.84+$2.9KTGRNF
6$20,023$989.77$16,392$1,304.77+$3.6KTGRNF
7$22,564$1,139.11$18,129$1,539.52+$4.4KTGRNF
8$25,456$1,312.45$20,173$1,827.08+$5.3KTGRNF
9$28,751$1,513.87$22,597$2,181.81+$6.2KTGRNF
10$32,512$1,748.22$25,491$2,622.67+$7.0KTGRNF

TGRNF vs NNN: Complete Analysis 2026

TGRNFStock

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Full TGRNF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this TGRNF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TGRNF vs SCHDTGRNF vs JEPITGRNF vs OTGRNF vs KOTGRNF vs MAINTGRNF vs ADCTGRNF vs EPRTTGRNF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.